Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lidan Hao"'
Autor:
Lidan Hao, Haiyang Chen, Lili Wang, Hanqiong Zhou, Zhe Zhang, Jing Han, Jiabao Hou, Yichen Zhu, He Zhang, Qiming Wang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 11, Pp 1036-1041 (2023)
Abstract The transformation from non‐small‐cell lung cancer (NSCLC) to small‐cell lung cancer (SCLC) is one of the mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) resistance. Previous studies exhibited th
Externí odkaz:
https://doaj.org/article/7e0f79432a614257b9e39f0cfc3e6110
Autor:
Jiabao Hou, Hongle Li, Shuxiang Ma, Zhen He, Sen Yang, Lidan Hao, Hanqiong Zhou, Zhe Zhang, Jing Han, Li Wang, Qiming Wang
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-12 (2022)
Abstract Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The discovery of epidermal growth factor receptor (EGFR) gene mutations and the development of EGFR tyrosine kinase inhibitors (TKIs) marked the beginning
Externí odkaz:
https://doaj.org/article/9638b5ed115d47ee9c337919d9ac6e73
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5620-5631 (2020)
Abstract LncRNAs play crucial roles in the development of various cancers including hepatocellular carcinoma (HCC). Nevertheless, the function of the long noncoding RNA (lncRNA) FOXD2‐AS1 in HCC is still poorly understood. In this study, we focused
Externí odkaz:
https://doaj.org/article/21ce6ab460c44d08bbf7a67f8ca0a6cb
Autor:
Peng, Li, Lidan, Hao, Cuicui, Zhang, zhe, Zhang, sen, Yang, Xuan, Wu, Ganghua, Li, Chao, Zhang, Zhensheng, Liu, Qiming, Wang
Publikováno v:
In Lung Cancer June 2024 192
Autor:
Cheng Cheng, Xuan Wu, Wenping Song, Dongbei Li, Lidan Hao, Xiaojing Li, Wenzhou Zhang, Ding Li
Publikováno v:
Translational andrology and urology. 11(11)
The Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist was developed to improve the reporting quality in clinical practice guidelines (CPGs). CPGs could provide the recommendations for key clinical issues with alternative care op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc62a2c9d9e14e2377b32175819298e
https://pubmed.ncbi.nlm.nih.gov/36507483
https://pubmed.ncbi.nlm.nih.gov/36507483
Autor:
Jiabao Hou, Qiming Wang, Yanfang Ma, Jing Han, Sen Yang, Hanqiong Zhou, Xuan Wu, Zhe Zhang, Jonathan Spicer, Young Wha Koh, Lidan Hao, Tetsuya Mitsudomi, Noemi Reguart, Mariano Provencio
Publikováno v:
Transl Lung Cancer Res
Background To systematically assess the consistency of recommendations regarding diagnosis and treatment of non-small cell lung cancer (NSCLC) in clinical practice guidelines (CPGs). Methods We systematically searched relevant literature databases an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc8f689ecd4b405e33a51ad158820fd
https://doi.org/10.21037/tlcr-21-423
https://doi.org/10.21037/tlcr-21-423
Autor:
Jiabao Hou, Qiangqiang Guo, Hanqiong Zhou, Xuan Wu, Lidan Hao, Zhe Zhang, Shuxiang Ma, Jing Han, Zhen He, Zhensheng Liu, Yaolong Chen, Qiming Wang
Publikováno v:
Translational cancer research. 11(6)
Head and neck cancer (HNC) comprises a heterogeneous group of cancers. In view of the distinct biological characteristics and treatment strategies, clinical physicians require high-quality clinical practice guidelines (CPGs) which could provide relia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303bdd3dcb845a6231d7ec2947c07d52
https://pubmed.ncbi.nlm.nih.gov/35836513
https://pubmed.ncbi.nlm.nih.gov/35836513
Publikováno v:
Oncology (08909091); Mar2023, Vol. 37 Issue 3, p130-141, 12p
Publikováno v:
Annals of Translational Medicine. 10:1235-1235
Kidney renal clear cell carcinoma (KIRC) is considered an immunogenic tumor. Cuproptosis is a newly identified copper-induced regulated cell death that relies on mitochondria respiration. Long noncoding RNAs (lncRNAs) have emerged as significant play
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498b6db9259afb6c8bbdc7a1fa3fb789
https://doi.org/10.21037/atm-22-5204
https://doi.org/10.21037/atm-22-5204
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss, Pp-(2019)
T cells edited by chimeric antigen receptors (CAR) have shown great potential in the treatment of tumors, especially malignant blood tumors. However, there remain many obstacles in the CAR-T therapy against solid tumors, such as the expansion of CAR-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8a1e16179c7613366445563c180d4c
http://www.sciencedirect.com/science/article/pii/S075333221932877X
http://www.sciencedirect.com/science/article/pii/S075333221932877X